# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Alexander the Great (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC002-SYN
- Date: 2026-03-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Theodora Papadakis-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review, seen the same day by pulmonology and by the addiction medicine clinician. **S**

## History of present illness

Alexander has taken acetaminophen two or three times a day, within the limit, and it takes the edge off the chest pain without stopping it; the pain is still 6 of 10 on climbs and deep breaths and wakes him when he rolls onto his left side. He has been to two banquets since intake and drank less at both, about six drinks each, and none on other days. He has had no shakes, sweats or morning drinking. He has met the behavioral health clinician once and talked about his companion for the first time. He had a CT of the chest this morning and lung volumes and a six-minute walk before this visit, and sees Dr. Abernathy-Sowande of pulmonology this afternoon. He met the clinic's addiction medicine clinician this morning. **S**

| Element | Detail |
|---|---|
| Chest wall pain | 6 of 10 on exertion; wakes him lying on the left |
| CT of the chest | Localized left pleural thickening with a thin calcified rim; healed fifth rib fracture; no retained fragment, fistula or trapped lung |
| Lung volumes | TLC 5.28 L (79 percent predicted); DLCO 31.4 (normal) |
| Six-minute walk | 548 m; oxygen saturation 98 to 96 percent |
| Alcohol | Two banquets, about six drinks each; no withdrawal |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Positive | Breathless on long climbs; no cough, sputum or blood |
| Musculoskeletal | Positive | Pain at the left chest scar |
| Constitutional | Negative | No fevers or weight loss |
| Psychiatric | Positive | Sad, sleeping poorly; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for chest wall pain, no more than 2,000 mg in a day while he is drinking heavily **S**
- Thiamine 100 mg oral tablet once daily for three months **S**
- Lidocaine 5% medicated patch, one patch over the painful scar for up to 12 hours in each 24 hours **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 72 kg; BMI 24.9 kg/m². All vital signs are synthetic.

Total lung capacity (body plethysmography): 5.28 L (low); TLC percent predicted: 79% (low); DLCO: 31.4 mL/min/mm[Hg]; 6-minute walk distance: 548 m; Chest wall pain (0 to 10): 6. All results are synthetic.

## Change since baseline

- Chest wall pain (0 to 10): 6 at baseline, 6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 128/80, pulse 76; weight 72.0 kg |
| Respiratory | Slightly reduced expansion and breath sounds at the left base; dull to percussion there; no crackles or wheeze |
| Musculoskeletal | Healed 3 cm scar in the left fourth intercostal space in the anterior axillary line; tenderness along the fifth rib and the intercostal space below the scar; a 4 by 3 cm area of allodynia around the scar |
| Psychiatric | Engaged; sad when he speaks of his companion; no thoughts of suicide |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Chronic post-traumatic chest wall pain** (G89.21). Dr. Abernathy-Sowande agrees that the pain is intercostal neuropathic pain at the healed wound and rib fracture, not pleural or cardiac pain. Opioids, tramadol, gabapentinoids and benzodiazepines are avoided while he drinks heavily. **S**
   - Lidocaine 5% patch over the scar for up to 12 hours a day from today.
   - Continue acetaminophen within 2,000 mg a day.
   - Telephone check on the patch in four weeks.
   - An intercostal nerve block if pain stays above 4 of 10 after six weeks.
2. **Localized left fibrothorax after an old hemothorax** (J94.1). Localized pleural thickening with a mild restrictive defect from outside the lung (TLC 79 percent, normal DLCO with a high KCO) and a normal six-minute walk; no retained fragment, fistula or trapped lung. Decortication is not indicated. **S**
   - Physical therapy for thoracic mobility and scar desensitization, deep-breathing exercises, and graded training back to long marches.
   - Repeat spirometry in about two months.
3. **Alcohol use disorder, mild** (F10.10). With the addiction medicine clinician this morning: three DSM-5-TR criteria (more than intended, riding after drinking, and arguments while drunk), a mild disorder. No withdrawal risk with his pattern. He chose a moderation goal: no more than four drinks on any day and fourteen in a week, two alcohol-free days, and no riding or driving after drinking. Naltrexone was offered; he declined for now. **S**
   - Sessions with the addiction medicine clinician every two weeks.
   - PEth and liver tests at six weeks.
   - Naltrexone offered again if he cannot keep the goal.
4. **Bereavement with depressive symptoms** (Z63.4). Grief five months after his companion's death, with sadness and poor sleep. Safety reviewed: no thoughts of suicide or self-harm; service pistol in the armory off duty; 988 card carried. **S**
   - Behavioral health sessions every two weeks.
   - PHQ-9 at six weeks.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Chest wall pain score (0 to 10) and examination of the scar and ribs | Every visit | Completed today | 6 of 10; tender fifth rib and intercostal space; allodynia around the scar |
| Imaging | CT of the chest for a retained fragment, fibrothorax or trapped lung | Once, for symptoms after a penetrating chest wound | Completed today | No retained fragment, fistula, loculated fluid or trapped lung; localized pleural thickening up to 7 mm with a thin calcified rim |
| Imaging | Lung volumes and diffusing capacity | Once, to confirm restriction suggested by spirometry | Completed today | TLC 5.28 L, 79 percent predicted (mild restriction); DLCO 31.4 mL/min/mmHg, normal |
| Imaging | Six-minute walk with oxygen saturation | At baseline of an exercise program | Completed today | 548 m; saturation 98 to 96 percent; Borg 3 |
| Imaging | Spirometry (ATS/ERS 2019 quality) | At diagnosis, and two to three months into the exercise program | Up to date | FVC 78 and FEV1 79 percent predicted with a ratio of 0.84 at intake; repeat in about two months |
| Medication safety | Analgesic safety: acetaminophen limit; no opioids, tramadol, gabapentinoids or benzodiazepines | Every visit | Completed today | Acetaminophen within 2,000 mg a day; no opioid or sedating medicine |
| Medication safety | Lidocaine patch: effect and skin check | At the start and at four weeks | Completed today | Started today |
| Self-management | Physical therapy and the breathing and exercise program | Weekly physical therapy for six weeks, home exercises daily | Completed today | Program set today |
| Survey | Drinking since the last visit (self-report against his goal) | Every visit | Completed today | Two banquets with about six drinks each; none on other days |
| Survey | DSM-5-TR assessment and drinking goal | At diagnosis | Completed today | Three criteria, mild; moderation goal chosen |
| Medication safety | Withdrawal risk | At diagnosis and with any change in drinking | Completed today | No withdrawal symptoms and no daily drinking; low risk |
| Laboratory | PEth | At baseline and every four to six weeks while drinking is changing | Up to date | 236 ng/mL at intake; next at six weeks |
| Laboratory | Liver tests (AST, ALT, GGT) | At baseline and four to six weeks later | Up to date | AST 52, GGT 96 U/L at intake; next at six weeks |
| Medication safety | Medicine for alcohol use disorder offered | At diagnosis and if the goal is not met | Completed today | Naltrexone offered; declined for now |
| Referral | Sessions with the addiction medicine clinician | Every two weeks | Completed today | First session today |
| Referral | Pulmonology consultation | At diagnosis | Completed today | Seen by Dr. Abernathy-Sowande today |
| Survey | PHQ-9 (item 9 reviewed) | At intake, then every four to six weeks while symptoms are active (no antidepressant) | Up to date | 12 at intake, item 9 scored 0; next at six weeks |
| Referral | Sessions with the behavioral health clinician | Every two weeks | Completed today | First session done |
| Survey | Suicide-risk review, lethal means, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; pistol in the armory off duty; 988 card carried |
| Medication safety | Thiamine | Daily for three months | Completed today | Taking it daily |

## Goal progress

- Find out why the old wound still hurts and why he is breathless, and whether anything remains in the chest. Outcome by 2026-03-23: Post-traumatic intercostal pain and a localized fibrothorax with mild restriction; no retained fragment, fistula or trapped lung; no surgery needed. **S**
- Chest wall pain 3 of 10 or less on exertion, without opioids. In progress; target 2026-05-11. **S**
- Back to long marches and runs without stopping for breath. In progress; target 2026-08-10. **S**
- No more than four drinks on any day and fourteen in a week, no riding or driving after drinking, and two or more alcohol-free days a week. In progress; target 2026-08-10. **S**
- Sleep seven hours, and room to grieve. In progress; target 2026-08-10. **S**

## Medication changes

- Started: Lidocaine 5% medicated patch, one patch over the painful scar for up to 12 hours in each 24 hours **S**

## Guideline basis

- ERS/ATS technical standard on interpretive strategies for routine lung function tests (2022), European Respiratory Society and American Thoracic Society (Eur Respir J 2022;60(1):2101499)
- British Thoracic Society Guideline for pleural disease (2023), British Thoracic Society (Thorax 2023;78(Suppl 3):s1-s42)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression monograph (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Six-week review with PEth, liver tests, PHQ-9 and a pain score. Telephone check on the patch in four weeks. Physical therapy weekly; addiction medicine and behavioral health every two weeks. The clinic or 988 at any hour. **S**
- Next scheduled visit 2026-04-20: six-week review: chest wall pain and the exercise program, drinking and PEth, liver tests, grief and mood, safety, and the healed forearm wound. **S**
